BRIEF-PainReform Provides Further Update On Phase 3 Clinical Trial Of PRF-110

Dec 27 (Reuters) - PainReform Ltd PRFX.O:

• PAINREFORM PROVIDES FURTHER UPDATE ON PHASE 3 CLINICAL TRIAL OF PRF-110

• PAINREFORM LTD: DATA FROM FINAL 24-HOUR PERIOD COULD NOT BE CLARIFIED TO SATISFY STUDY'S PRIMARY ENDPOINT 72 HOURS REQUIREMENT

• PAINREFORM LTD: DATA FROM FINAL 24-HOUR PERIOD DID NOT MEET PRIMARY ENDPOINT OF STUDY

• PAINREFORM LTD - INITIATES RESEARCH AND DEVELOPMENT ACTIVITIES TO REFINE PHARMACO-KINETICS AND PHARMACO-DYNAMICS OF PRF-110

Source text: ID:nGNX6zvpVc

Further company coverage: PRFX.O

((Reuters.Briefs@thomsonreuters.com;))